Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Breast most cancers therapy is advancing quickly, says Dr. Erika Hamilton, board-certified medical oncologist and director of Breast Most cancers and Gynecologic Most...
The panel dialogue continued with a affected person sharing their private expertise of being identified with a number of myeloma. Initially, the person...
The dialogue shifted to therapy concerns for a number of myeloma, specializing in how choices are influenced by each patient-specific and disease-specific elements....
